Enitociclib (VIP152/formerly BAY1251152) Is a Selective and Active CDK9 Inhibitor : Preliminary Safety and Early Signs of Efficacy in Patients with Non-Hodgkin Lymphoma (NHL) and Chronic Lymphocytic Leukemia (CLL)
慢性淋巴细胞白血病
医学
淋巴瘤
内科学
白血病
作者
Mazyar Shadman,Anthony R. Mato,Connie Lee Batlevi,Ian W. Flinn,Martin Gutierrez,Marc Uemura,Don A. Stevens,Daniel Morillo,John C. Byrd,Melanie M. Frigault,George Clemens,Xin Huang,Raquel Izumi,Harvey Wong,Renee Breed,Hermes Garban,Amy J. Johnson,Beatrix Stelte-Ludwig,Arushi Mithal,Joseph Birkett,Ahmed Hamdy,Kerry A. Rogers
出处
期刊:Blood [American Society of Hematology] 日期:2022-11-15卷期号:140 (Supplement 1): 9454-9456